Anika Therapeutics (ANIK) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $20.42 -2.25%
Revenue Growth %: +7.0%
Financial Fact:
Net income: 8.95M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +7.0%
Financial Fact:
Net income: 8.95M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q4 EPS of $0.54, $0.01 better than the analyst estimate of $0.53. Revenue for the quarter came in at $28.7 million versus the consensus estimate of $27.84 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Interactive Strength reports record Q2 results, raises Q3 guidance
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
